Core Laboratories: Zacks Research Has Pessimistic Outlook of CLB Q3 Earnings

Core Laboratories Inc. ( NYSE:CLB - Free Report ) - Analysts at Zacks Research dropped their Q3 2025 EPS estimates for Core Laboratories in a research report issued on Friday, January 17th. Zacks Research analyst T. Saha now expects that the oil and gas company will post earnings of $0.27 per share for the quarter, down from their previous forecast of $0.28. The consensus estimate for Core Laboratories' current full-year earnings is $0.80 per share. Zacks Research also issued estimates for Core Laboratories' Q1 2026 earnings at $0.24 EPS and Q3 2026 earnings at $0.32 EPS. Core Laboratories ( NYSE:CLB - Get Free Report ) last issued its earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.04. The business had revenue of $134.40 million for the quarter, compared to the consensus estimate of $134.16 million. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. The business's quarterly revenue was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.22 earnings per share. Check Out Our Latest Research Report on Core Laboratories Core Laboratories Stock Up 3.3 % Shares of NYSE:CLB opened at $19.73 on Monday. The company has a market cap of $926.51 million, a price-to-earnings ratio of 30.36, a PEG ratio of 0.98 and a beta of 2.39. The firm's 50-day simple moving average is $19.10 and its 200-day simple moving average is $19.56. The company has a quick ratio of 1.79, a current ratio of 2.48 and a debt-to-equity ratio of 0.55. Core Laboratories has a fifty-two week low of $13.82 and a fifty-two week high of $25.13. Core Laboratories Dividend Announcement The firm also recently announced a quarterly dividend, which was paid on Monday, November 25th. Shareholders of record on Monday, November 4th were given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.20%. The ex-dividend date was Monday, November 4th. Core Laboratories's payout ratio is currently 6.15%. Hedge Funds Weigh In On Core Laboratories Institutional investors have recently modified their holdings of the company. Nisa Investment Advisors LLC raised its position in shares of Core Laboratories by 2,688.5% in the fourth quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company's stock valued at $42,000 after buying an additional 2,339 shares during the last quarter. nVerses Capital LLC purchased a new stake in Core Laboratories in the third quarter valued at approximately $48,000. Northwestern Mutual Wealth Management Co. grew its holdings in Core Laboratories by 11.9% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 5,636 shares of the oil and gas company's stock valued at $114,000 after purchasing an additional 600 shares during the period. GAMMA Investing LLC grew its holdings in Core Laboratories by 33.0% in the third quarter. GAMMA Investing LLC now owns 5,885 shares of the oil and gas company's stock valued at $109,000 after purchasing an additional 1,460 shares during the period. Finally, Isthmus Partners LLC grew its holdings in Core Laboratories by 18.8% in the third quarter. Isthmus Partners LLC now owns 10,620 shares of the oil and gas company's stock valued at $197,000 after purchasing an additional 1,682 shares during the period. Institutional investors and hedge funds own 97.81% of the company's stock. Core Laboratories Company Profile ( Get Free Report ) Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. Recommended Stories Five stocks we like better than Core Laboratories How to Effectively Use the MarketBeat Ratings Screener 3 Stocks to Gain From Donald Trump's External Revenue Service Biggest Stock Losers - Today's Biggest Percentage Decliners AMD: Loop Capital's Buy Rating Reinforces Investor Confidence Mastering Discipline: Overcoming Emotional Challenges In Trading Momentum Is Building for Qualcomm to Have a Strong Run in 2025 Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter .